Novartis | NVS - Kreditur Perdagangan

Harga Saham
161.01
Perubahan Harian
-4.46 -2.70%
Bulanan
2.93%
Tahunan
42.41%
Q1 Perkiraan
164.51




Kreditur Perdagangan Perubahan Tanggal
AbbVie USD 3.59B 28.65B 2025-12
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Bausch Health Companies USD 600M 16M 2025-12
Biogen USD 432M 18.9M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Canopy Growth CAD 18.14M 5.94M 2025-09
Corcept Therapeutics USD 40.44M 6M 2025-12
Drreddys Laboratories INR 454.04M 854K 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 21.07B 7.42B 2025-09
J&J USD 11.99B 2.37B 2025-12
Merck USD 4.15B 102M 2025-09
Novartis USD 4.56B 49M 2025-09
Novartis USD 4.56B 49M 2025-09
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
Phibro Animal Health USD 133.3M 2.7M 2025-12
Prestige Brands USD 42.95M 1.02M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.93B 927M 2025-12
Sanofi EUR 22.93B 2.89B 2025-12
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Zoetis USD 487M 77M 2025-12